Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Baudax Bio, Inc.BXRX · Entity 109081 | Chief Financial Officer | January 15, 2021 | January 20, 2021 |
| LIFECORE BIOMEDICAL, INC. \DE\LFCR · Entity 6447 | Chief Financial Officer | September 03, 2025 | September 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Baudax Bio, Inc.
Report date January 15, 2021 · Filed January 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,251 |
Ending reported balance
After 2021-01-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-01-15 · Grant · Acquired 5,000 · Balance 75,909 F1: The restricted stock units are fully vested upon grant. Row 2 · 2021-01-15 · Grant · Acquired 20,000 · Balance 95,909 F1: The restricted stock units are fully vested upon grant. Row 3 · 2021-01-15 · Tax withholding · Disposed 26,658 · Balance 69,251 F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.30 · Expires 2023-01-15 | Direct | 23,077 |
Reported balance
After 2021-01-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-01-15 · Grant · Acquired 23,077 · Balance 23,077 F3: The stock option is fully vested upon grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.30 · Expires 2023-01-15 | Direct | 60,000 |
Reported balance
After 2021-01-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-01-15 · Grant · Acquired 60,000 · Balance 60,000 F3: The stock option is fully vested upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units are fully vested upon grant.
F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3: The stock option is fully vested upon grant.
LIFECORE BIOMEDICAL, INC. \DE\
Report date September 03, 2025 · Filed September 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 336,691 |
Reported balance
After 2025-09-03 transaction · row 1
1 source rowRow 1 · 2025-09-03 · Tax withholding · Disposed 22,932 · Balance 336,691 F1: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Societal CDMO, Inc.
Report date April 08, 2024 · Filed April 08, 2024
Section 16 reporting ended · disclosed 2024-04-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-04-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-04-08 · Other · Disposed 522,699 · Balance 1,049,287 F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation ("Parent") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the "Effective Time") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the "Offer Amount"), subject to any applicable withholding taxes and without interest. Row 2 · 2024-04-08 · Disposition to issuer · Disposed 1,049,287 · Balance 0 F2: Represents restricted stock units granted under an Issuer equity plan ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation ("Parent") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the "Effective Time") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the "Offer Amount"), subject to any applicable withholding taxes and without interest.
F2: Represents restricted stock units granted under an Issuer equity plan ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 20, 2019 Filed Jan 23, 2019 16:05 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,880 | $7.99 | $15,021.20 |
DisclosureSEC source: 0001192482-19-000033 · edgar.xml · nonDerivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,155 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 20, 2019 Filed Jan 23, 2019 16:05 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 5,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-19-000033 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,035 F2 · shares: On January 20, 2019, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 5,750 performance-based restricted stock units granted in a prior year, which were converted into 5,750 shares of common stock on a one-for-one basis. F2 · price: On January 20, 2019, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 5,750 performance-based restricted stock units granted in a prior year, which were converted into 5,750 shares of common stock on a one-for-one basis. Read SEC document |
| January 20, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,880 | $7.99 | $15,021.20 |
DisclosureSEC source: 0001192482-19-000092 · edgar.xml · nonDerivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,748 F3 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 20, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 5,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-19-000092 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,628 F2 · shares: On January 20, 2019, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 5,750 performance-based restricted stock units granted in a prior year, which were converted into 5,750 shares of common stock on a one-for-one basis. F2 · price: On January 20, 2019, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 5,750 performance-based restricted stock units granted in a prior year, which were converted into 5,750 shares of common stock on a one-for-one basis. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 16:05 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantEmployee Stock Option (right to buy) · Derivative | 53,859 | $0.00 Strike: $7.99 | $0.00 |
DisclosureSEC source: 0001192482-19-000033 · edgar.xml · derivative · entry 4 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,859 Underlying: Common Stock · 53,859 shares Expires 2029-01-18 F4 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. Read SEC document |
| January 18, 2019 Filed Jan 23, 2019 16:05 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 11,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000033 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,285 F1 · shares: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
| January 18, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | GrantEmployee Stock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $7.99 | $0.00 |
DisclosureSEC source: 0001192482-19-000092 · edgar.xml · derivative · entry 4 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2029-01-18 F5 · shares: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted. F4 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. Read SEC document |
| January 18, 2019 Filed Feb 19, 2019 16:12 UTC Amendment | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 12,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000092 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,878 F1 · shares: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. F5 · shares: Due to a clerical error, the reporting person is filing this Amendment to correct the number of options and restricted stock units granted. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 17:39 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 979 | $7.41 | $7,254.39 |
DisclosureSEC source: 0001192482-19-000018 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,021 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:37 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 979 | $7.41 | $7,254.39 |
DisclosureSEC source: 0001192482-19-000011 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,021 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 16:33 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000277 · edgar.xml · derivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 16:33 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-18-000277 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:56 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantEmployee Stock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $9.04 | $0.00 |
DisclosureSEC source: 0001192482-18-000027 · edgar.xml · derivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2028-01-02 F2 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 20:56 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 11,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-18-000027 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · shares: All shares of common stock are represented by unvested restricted stock units that will vest in four equal annual installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 16:02 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001123292-17-001103 · edgar.xml · derivative · entry 2 Lake Ryan David · CIK 0001450325 · Senior VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning June 5, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The restricted stock unit award is an inducement grant under NASDAQ listing rule 5635(c)(4). F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning June 5, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The restricted stock unit award is an inducement grant under NASDAQ listing rule 5635(c)(4). Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 16:02 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantEmployee Stock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $7.58 | $0.00 |
DisclosureSEC source: 0001123292-17-001103 · edgar.xml · derivative · entry 1 Lake Ryan David · CIK 0001450325 · Senior VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2027-06-05 F1 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. The stock option is an inducement grant under NASDAQ listing rule 5635(c)(4). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.